What was the Value of the Infusion Pumps Market in 2030?

Infusion Pumps Market
Infusion Pumps Market

Infusion Pumps Market Overvuew

The global infusion pumps market was valued at $12,825.9 million in 2021, which is predicted to reach $27,133.7 million by 2030, at a compound annual growth rate of over 8.7% between 2021 to 2030.

The surging popularity of home infusion solutions, growing cases of chronic diseases, rising aging population, and increasing prevalence of hospital-acquired illnesses are the key factors responsible for market growth.

The revenue share of the homecare settings category was over 30% in 2021, and the category is predicted to grow at the highest rate in the coming years. This will be due to an increase in the incidence of chronic diseases, such as cardiovascular diseases, respiratory ailments, and diabetes, as well as the increasing older population and high cost of hospitalization.

Business Strategies

The accessories and consumables category held the largest share of the infusion pumps market, and this is likely to maintain this position in the coming years. This is owing to the global availability of a wide range of accessories and consumables and their frequent purchases.

The demand for traditional infusion pumps is expected to expand at a CAGR of about 10% in the coming years. This might be due to an increase in the requirement for these pumps in homecare and long-term-care settings for providing antibiotics, analgesics, chemotherapeutic medicines, and hydration fluids.

In 2021, the diabetes management category had an over 30% share of the infusion pumps market, and it is expected to grow in the future. This is credited to the rising global incidence of diabetes and technological advancements.

Strategic Insights

The cases of diabetes are on the rise in Europe, affecting people of all ages. In the EU, around 17 million adults were diagnosed with diabetes in 2000, which reached 35 million in 2019.

Smiths Medical, including its portfolio of vascular access devices, vital care products, syringes, and ambulatory infusion devices, was acquired by ICU Medical Inc. from Smiths Group plc in January 2022.

Similarly, Medtronic plc acquired Klue, a provider of behavior tracking software that can give real-time insights into whenever a person is eating, in December 2019. The Medtronic Personalized Closed Loop (PCL) insulin pump device is using Klue’s technology.

Sales Analysis

Due to the existence of numerous big companies, the infusion pumps market is competitive. Such companies are actively involved in collaborations and partnerships to maintain their position. Major companies are Eli Lilly and Company, Terumo Corporation, Pfizer Inc., Nipro Corporation, ICU Medical Inc., Medtronic plc, CareFusion Corporation, B Braun Melsungen AG, Becton, Dickinson and Company, and Baxter International Inc.

Patients are shifting from the expensive hospitals to less-expensive alternative facilities, such as homecare and diabetic clinics/centers. Home infusion treatment is quickly gaining popularity among diabetes patients as modern insulin delivery devices have become widely available.

Infusion Pumps Market Segmentation Analysis

Product Type

  • Devices
    • Volumetric
    • Insulin
    • Enteral
    • Syringe
    • Ambulatory
    • Patient-controlled analgesia (PCA)
    • Implantable
  • Accessories and Consumables


  • Specialty
  • Traditional


  • Chemotherapy/Oncology
  • Diabetes Management
  • Gastroenterology
  • Pain Management/Analgesia
  • Pediatrics/Neonatology

End User

  • Hospitals
  • Homecare Settings
  • Ambulatory Care Settings


  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • Spain
    • U.K.
    • Italy
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America (LATAM)
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • South Africa

Browse More Related Reports

Cardiac Monitoring Market Size, Business Strategies, and Regional Outlook

Key Findings of Cardiac Monitoring Market Report

  • In 2021, the North American cardiac monitoring marketaccounted for $2,998.3 million in revenue, which will rise at a CAGR of 8.7% from 2021 to 2030. The increasing healthcare expenditure, growing prevalence of CVDs, advancing disposable income, and increasing healthcare knowledge drive the market in the region
  • Boston Scientific Corporation bought Preventice Solutions Inc. in January 2021 to offer portable ambulatory cardiac monitors and other devices that are essential to sound heart health.
  • Similarly, ZOLL Medical Corporation declared the purchase of Cardiac Science Corporation in August 2019 to increase AED production for cardiac monitoring and deliver related accessories and services.
  • The early identification of arrhythmias can help prevent serious heart events; as a result, the demand for cardiac monitoring devices is increasing since these devices can save patients in whom the risk of sudden cardiac arrest is high.
  • In 2021, hospitals produced approximately $3,070.3 million in cardiac monitoring market revenue, and it is expected to grow at a 7.8% CAGR in the forecast period. Every year, around 6.9% of the patients with ischemic heart disease or a history of myocardial infarction are hospitalized in the U.S. While, approximately 7.2% of the patients with heart illnesses end up in emergency rooms.
  • In China and the U.A.E., 58% and 46% of the patients, respectively, send data to healthcare experts via connected devices. In contrast, the percentages are roughly 12%, 17%, and 26% in Germany, Sweden, and the U.K., respectively.


Needle-Free Diabetes Management Market Size, Business Strategies, and Regional Outlook

Factors such as the soaring prevalence of diabetes and the surging awareness about safety issues associated with the use of needles will drive the needle-free diabetes management market at a CAGR of 17.8% during the forecast period (2017–2025). According to P&S Intelligence, the market revenue will surge from $3,830.6 million in 2016 to $16.8 billion by 2025. Needle-free diabetes management refers to the diagnosis, monitoring, and treatment of diabetes without using needles. Needle-free diabetes management devices are used for monitoring blood sugar levels and injecting insulin in diabetic patients.

One of the key contributors to the market growth is the burgeoning cases of diabetes worldwide. As per the World Health Organization (WHO), diabetes is a metabolic disease that is characterized by elevated levels of blood sugar and have a detrimental impact on the heart, eyes, kidneys, nerves, and blood vessels. The WHO states that approximately 422 million people across the world are currently living with this chronic disease. Furthermore, the International Diabetes Federation (IDF) forecasts that around 700 million people within the age group of 20–79 years will be affected by diabetes, by 2045.


Endoscope Market Size, Business Strategies, and Regional Outlook

Every year, cancer kills 9.6 million people and cardiovascular diseases (CVDs) 17.9 million people, as per the World Health Organization (WHO). Effective and early diagnosis are now known to be the keys to reducing the mortality rate of such diseases. For diagnosis, doctors often need to look directly inside the body to see the issue. This is why a variety of endoscopic procedures have been developed, so that the insides of the human body can be looked at and anomalies detected.

As per P&S Intelligence, the rising prevalence of chronic diseases will be the strongest driver for the growth of the endoscope market from $18.9 billion in 2018 to $28.4 billion in 2024, at a 7.2% CAGR during the forecast period (2019–2024). An endoscope consists of camera and small light bulb connected to a viewing lens by a tube thin enough to be inserted through the major pipes in the body toward a particular organ.


Ambulatory EHR Market Size, Business Strategies, and Regional Outlook

Globally, the ambulatory EHR market is driven by the initiatives taken by various governments for encouraging the adoption of EHR systems. Essentially, the increasing usage of healthcare information technologies (HITs) is raising the demand for ambulatory EHR across the world. As is the strong need for reducing the overall cost of healthcare. EHRs are digital records of the healthcare services provided to patients. They may include lab and radiology reports, diagnoses, prescriptions, appointment.   Procedure schedules, and payment and insurance data.

HITs are being used for managing health information with the help of computer systems. Allowing a secured exchange of healthcare information between providers and patients. According to government sources, the adoption of EHR solutions among doctors in the U.S. stood at 86% in 2017. The National Center for Health Statistics (NCHS) also reported that pediatricians, obstetricians. General practitioners are the primary users of EHR systems. This is because these solutions, especially those available via the cloud, offer patients. Doctors access to the health information from anywhere, at any time.


Insulin Delivery Devices Market Size, Business Strategies, and Regional Outlook

The insulin delivery devices market 2030 revenue will likely be $39,371.8 million, compared to an estimated $16,008.0 million in 2021, growing at a healthy 10.5% CAGR. Among all the devices used for administering this peptide hormone into the body, insulin pens are used the most. Pens are easier to use by individuals on themselves compared to syringes and cheaper compared to insulin pumps and other devices.

Moreover, reusable pens are cost-effective in the long run, as a single pen can be used for a long time just by simply changing the vial/refill. Therefore, seeing the growing popularity of these devices, companies that produce them are enhancing their sales and distribution network in countries with a large diabetic population, such as China and India. Similarly, in developed countries, technologically advanced pens and ample medical reimbursements on their purchase are available.



About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.


P&S Intelligence
Phone: +1-347-960-6455
Email: [email protected]
Web: https://www.psmarketresearch.com



Above all,most importantly,
certainly,That is to say,
in other words,to clarify,
Therefore,as a result,
In conclusion,to sum up,
in short

Above all,most importantly,
certainly,That is to say,
in other words,to clarify,
Therefore,as a result,
In conclusion,to sum up,
in short

Above all,most importantly,
certainly,That is to say,
in other words,to clarify,
Therefore,as a result,
In conclusion,to sum up,
in short

Above all,most importantly,
certainly,That is to say,
in other words,to clarify,
Therefore,as a result,
In conclusion,to sum up,
in short


Please enter your comment!
Please enter your name here